Mexico responds to US salmonella outbreak linked to papayas
Mexico's food safety agency says it is "premature" to point to Mexican papayas as the source of a salmonella outbreak in the U.S. One person in New York has died of the disease and 46 have fallen ill in 12 other states.
Facebook and Verizon advance while AstraZeneca dives
Stocks that moved substantially or traded heavily Thursday: Facebook Inc., up $4.83 to $170.44
Medicaid a 'hand-up' not a 'hand-out,' National Down Syndrome Society pres. says
As Congress continues to battle over healthcare reform, the bill’s proposed cuts to Medicaid would drastically impact critical funding for Americans with disabilities.
Germans find illegal emissions device in Porsche model
Germany's transport minister says that what authorities consider illegal software has been found in a Porsche diesel model, and they will order a recall of the cars.
ObamaCare repeal: Vote-a-rama, 'skinny repeal' and what comes next
What's in the 'skinny repeal'? The exact details are still being worked out, but in a process called vote-a-rama, expected to begin Thursday, lawmakers can propose unlimited amendments to be voted on.
Shares in AstraZeneca dive as key cancer drug trial fails
Anglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid declining sales of blockbuster drugs Crestor and Seroquel XR, which lost patent protection in the United States last year.
World stocks mixed amid raft of corporate earnings
Asian shares were mostly higher Thursday, supported by strong corporate earnings and the Federal Reserve's decision to pause its slow-moving campaign to raise interest rates.
Bristol-Myers beats Street 2Q forecasts
Bristol-Myers Squibb Co. (BMY) on Thursday reported second-quarter earnings of $916 million.
AstraZeneca shares plunge 15% as lung cancer study fails
AstraZeneca's combination of two injectable immunotherapy drugs failed to help patients as hoped in a closely watched advanced lung cancer trial, sending its shares plunging on Thursday.
The Latest; Governors urge bipartisan work on healthcare
The Latest on the effort by congressional Republicans to pass a health care bill (all times local): 7:20 a.m.
FDA panel: Not enough data to OK "abuse-deterrent" opioid
A panel of Food and Drug Administration advisers voted against approving a new opioid painkiller with a unique feature for deterring abuse: It releases a deep-blue dye if someone tries to get high by crushing, chewing or snorting pills.
Senate rejects Obamacare repeal again, eyes a 'skinny' bill
Republicans in the U.S. Senate fell short again on Wednesday in their effort to end Obamacare, rejecting a measure to repeal large portions of President Barack Obama's signature law that has provided health insurance to millions of Americans.
How long will it take before a new health bill is passed?
Senate procedural vote
Ford recalling 117,000 vehicles for safety defect
Ford Motor Co. is recalling nearly 117,000 vehicles because the bolts in the seat, seat belt or seat belt buckle may fracture.
Dramatic Trump tax cuts are unlikely to pass Congress: Fmr. CBO Director
Corporate tax rate
Insurers want US government to pump billions into ObamaCare subsidies
U.S. health insurers want the federal government to shell out billions of dollars to continue funding for ObamaCare subsidies in order stabilize the insurance marketplace.
We have to find the path that gets 50 GOP votes: Sen. Thune
Senate ObamaCare repeal
Repealing ObamaCare without a replacement leaves millions uninsured: Fmr. Rep. Kucinich
Former Rep. Dennis Kucinich (D-Ohio) on Wednesday said that a single-payer health care system, like ObamaCare, would benefit the American people more than one that depends on the free market, which is proposed in the latest GOP health care bill.
Market based health care will hurt millions of Americans, says fmr. Rep. Kucinich
Health care reform debate
'Pharma Bro' won't stop talking, except to jury in trial
"Pharma Bro" Martin Shkreli (SHKREL'-ee) says on social media that he's being railroaded at his securities fraud trial, but he won't be defending himself in court.












